If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMDC.L Regulatory News (MDC)

  • There is currently no data for MDC

Form 8.3 - MEDICLINIC INTERNATIONAL PLC

12 Apr 2023 12:41

RNS Number : 0016W
Barclays PLC
12 April 2023
Β 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Β 

Barclays PLC.

(b)

Owner or controller of interest and short

Β 

Β 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

MEDICLINIC INTERNATIONAL PLC

Β 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

Β 

Β 

offeror/offeree, state this and specify identity of

Β 

offeror/offeree:

(e)

Date position held/dealing undertaken:

11 Apr 2023

(f)

In addition to the company in 1(c) above, is the discloser making

NO

Β 

Β 

Β 

disclosures in respect of any other party to the offer?

Β 

Β 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

Β 

Β 

to which the disclosure relates following the dealing(if any)

Β 

Class of relevant security:

10p ordinary

Β 

Interests

Short Positions

Β 

Number

(%)

Number

(%)

(1)

Relevant securities owned

Β 

Β 

Β 

Β 

Β 

and/or controlled:

Β 

Β 

15,850,953

2.15%

11,477,343

1.56%

(2)

Cash-settled derivatives:

Β 

Β 

Β 

Β 

Β 

and/or controlled:

Β 

Β 

11,270,667

1.53%

13,513,146

1.83%

(3)

Stock-settled derivatives (including options)

Β 

Β 

Β 

Β 

Β 

and agreements to purchase/sell:

Β 

Β 

0

0.00%

0

0.00%

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

TOTAL:

Β 

Β 

27,121,620

3.68%

24,990,489

3.39%

(b)

Rights to subscribe for new securities (including directors and other executive

Β 

Β 

options)

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant security in relation to

Β 

Β 

Β 

Β 

which subscription right exists

Β 

Β 

Β 

Β 

Details, including nature of the rights

Β 

Β 

Β 

Β 

concerned and relevant percentages:

Β 

Β 

Β 

Β 

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

Β 

Β 

Β 

Β 

Β 

Class of relevant

Purchase/sale

Number of

Price per unit

security

Β 

securities

Β 

10p ordinary

Purchase

19

4.9784 GBP

10p ordinary

Purchase

428

4.9779 GBP

10p ordinary

Purchase

699

4.9837 GBP

10p ordinary

Purchase

1,084

4.9844 GBP

10p ordinary

Purchase

1,474

4.9839 GBP

10p ordinary

Purchase

2,353

4.9840 GBP

10p ordinary

Purchase

2,444

4.9791 GBP

10p ordinary

Purchase

6,690

4.9820 GBP

10p ordinary

Purchase

64,627

4.9813 GBP

10p ordinary

Sale

102

4.9810 GBP

10p ordinary

Sale

1,136

4.9790 GBP

10p ordinary

Sale

1,285

4.9820 GBP

10p ordinary

Sale

1,763

4.9771 GBP

10p ordinary

Sale

8,637

4.9818 GBP

10p ordinary

Sale

13,351

4.9793 GBP

10p ordinary

Sale

61,577

4.9834 GBP

10p ordinary

Sale

171,796

4.9796 GBP

10p ordinary

Sale

200,000

4.9835 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(b)

Cash-settled derivative transactions

Β 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

Β 

reference

unit

security

Β 

Β 

securities

Β 

10p ordinary

SWAP

Long

102

4.9810 GBP

10p ordinary

SWAP

Long

1,168

113.4300 ZAR

10p ordinary

SWAP

Long

1,285

4.9820 GBP

10p ordinary

SWAP

Long

1,340

4.9819 GBP

10p ordinary

CFD

Long

1,381

113.2250 ZAR

10p ordinary

SWAP

Long

2,601

113.1611 ZAR

10p ordinary

CFD

Long

2,601

4.9781 GBP

10p ordinary

CFD

Long

2,749

113.0527 ZAR

10p ordinary

SWAP

Long

2,946

4.9826 GBP

10p ordinary

SWAP

Long

4,313

4.9839 GBP

10p ordinary

SWAP

Long

4,590

4.9840 GBP

10p ordinary

SWAP

Long

4,992

4.9811 GBP

10p ordinary

SWAP

Long

6,445

113.2088 ZAR

10p ordinary

SWAP

Long

13,147

4.9790 GBP

10p ordinary

SWAP

Long

20,791

4.9824 GBP

10p ordinary

CFD

Long

35,358

4.9835 GBP

10p ordinary

SWAP

Long

167,483

4.9794 GBP

10p ordinary

SWAP

Long

200,000

4.9835 GBP

10p ordinary

SWAP

Short

19

4.9785 GBP

10p ordinary

SWAP

Short

428

4.9779 GBP

10p ordinary

SWAP

Short

1,084

4.9844 GBP

10p ordinary

SWAP

Short

1,168

113.4300 ZAR

10p ordinary

SWAP

Short

1,381

113.2561 ZAR

10p ordinary

SWAP

Short

1,474

4.9839 GBP

10p ordinary

CFD

Short

2,601

113.1951 ZAR

10p ordinary

SWAP

Short

2,749

113.0866 ZAR

10p ordinary

CFD

Short

3,007

4.9844 GBP

10p ordinary

CFD

Short

6,445

113.2399 ZAR

10p ordinary

SWAP

Short

18,727

4.9804 GBP

10p ordinary

SWAP

Short

23,100

4.9818 GBP

10p ordinary

SWAP

Short

31,280

4.9813 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(c)

Stock-settled derivative transactions (including options)

Β 

(i)

Writing, selling, purchasing or varying

Β 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

Β 

date

money

relevant

Β 

selling,

securities

per unit

Β 

Β 

paid/

security

Β 

varying etc

to which

Β 

Β 

Β 

received

Β 

Β 

Β 

option

Β 

Β 

Β 

per unit

Β 

Β 

Β 

relates

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii)

Exercising

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

Β 

Β 

securities

unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d)

Other dealings (including subscribing for new securities)

Β 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

Β 

Β 

applicable)

Β 

Β 

Β 

Β 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding,

Β 

Β 

formal or informal, relating to relevant securities which may be an inducement to deal

Β 

Β 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

Β 

to the offer or any person acting in concert with a party to the offer:

Β 

Β 

Β 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between

Β 

Β 

the person making the disclosure and any other person relating to:

Β 

Β 

(i) the voting rights of any relevant securities under any option; or

Β 

Β 

Β 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

Β 

Β 

any derivative is referenced:

Β 

Β 

Β 

Β 

Β 

Β 

NONE

(c)

Attachments

Β 

Β 

Β 

Β 

Β 

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

12 Apr 2023

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETUUOAROKUSAAR
Date   Source Headline
26th May 20234:36 pmRNSForm 8 (DD) - Mediclinic International plc
26th May 20232:45 pmRNSForm 8.3 - MEDICLINIC INTERNATIONAL PLC
26th May 20231:00 pmRNSForm 8.3 - Mediclinic International plc
26th May 202311:33 amRNSForm 8.5 (EPT/NON-RI) - Mediclinic International p
26th May 202311:28 amRNSForm 8.5 (EPT/RI) - Mediclinic International plc
26th May 202311:18 amRNSForm 8.5 (EPT/NON-RI)-Mediclinic International plc
26th May 202310:45 amRNSForm 8.5 (EPT/RI)- Mediclinic International plc
26th May 20239:29 amRNSForm 8.5 (EPT/NON-RI)
26th May 20238:00 amRNSScheme of Arrangement becomes effective
26th May 20237:00 amRNSForm 8.3 - Mediclinic International plc
25th May 20233:20 pmRNSForm 8.3 - Mediclinic International plc
25th May 20232:57 pmRNSForm 8 (DD) - Mediclinic International plc
25th May 20232:39 pmRNSForm 8.5 (EPT/RI) - Mediclinic International plc
25th May 20232:12 pmRNSForm 8.3 - Mediclinic International plc
25th May 20232:00 pmRNSDirector/PDMR Shareholding
25th May 20232:00 pmRNSForm 8 (DD) - Mediclinic International plc
25th May 20232:00 pmRNSForm 8 (DD) - Mediclinic International plc
25th May 20232:00 pmRNSForm 8 (DD) - Mediclinic International plc
25th May 20231:37 pmRNSForm 8.5 (EPT/RI)- Replacement of Mediclinic
25th May 20231:00 pmRNSCourt Sanction of Scheme of Arrangement
25th May 202311:26 amRNSForm 8.5 (EPT/NON-RI) - Mediclinic International p
25th May 202311:25 amRNSForm 8.5 (EPT/RI) - Mediclinic
25th May 202310:48 amRNSForm 8.5 (EPT/NON-RI)-Mediclinic International plc
25th May 202310:34 amRNSForm 8.5 (EPT/RI)- Mediclinic International plc
25th May 202310:34 amRNSForm 8.5 (EPT/RI)
24th May 20233:20 pmRNSForm 8.3 - Mediclinic International plc
24th May 20232:17 pmRNSForm 8.3 - Mediclinic International PLC
24th May 202312:10 pmEQSForm 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
24th May 202312:00 pmRNSForm 8.3 - MEDICLINIC INTERNATIONAL PLC
24th May 202311:10 amRNSForm 8.5 (EPT/NON-RI)
24th May 202311:00 amRNSForm 8.5 (EPT/RI) - Mediclinic International plc
24th May 202311:00 amRNSForm 8.5 (EPT/RI) - Mediclinic Amendment
24th May 202311:00 amRNSForm 8.5 (EPT/NON-RI) - Mediclinic International
24th May 202310:32 amRNSForm 8.5 (EPT/NON-RI)-Mediclinic International plc
24th May 202310:18 amRNSForm 8.5 (EPT/RI)- Mediclinic International plc
24th May 20239:30 amRNSConsideration Currency Exchange Rate
23rd May 20234:47 pmRNSForm 8.5 (EPT/RI)-Replacement of Mediclinic
23rd May 20233:20 pmRNSForm 8.3 - Mediclinic International plc
23rd May 20233:19 pmRNSForm 8.3 - Mediclinic International plc
23rd May 20233:00 pmRNSForm 8.3 - Mediclinic International Plc
23rd May 202312:50 pmRNSForm 8 (DD) - Mediclinic International plc
23rd May 202312:19 pmRNSForm 8.3 - MEDICLINIC INTERNATIONAL PLC
23rd May 202311:39 amRNSForm 8.3 - Mediclinic International plc
23rd May 202311:21 amRNSForm 8.5 (EPT/RI) - Mediclinic
23rd May 202310:49 amRNSForm 8.5 (EPT/NON-RI) - Mediclinic
23rd May 202310:15 amRNSForm 8.5 (EPT/RI) - Mediclinic International plc
23rd May 202310:13 amRNSForm 8.5 (EPT/NON-RI)-Mediclinic International plc
22nd May 20236:01 pmRNSMediclinic International
22nd May 20233:42 pmRNSForm 8.3 - Mediclinic International Plc
22nd May 20233:34 pmRNSForm 8.3 - Mediclinic International Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.